Susan Pereira Ribeiro

A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates

Jennifer S. Wood, Muhammad Bilal Latif, A. Sette, 2021, Science Immunology.

Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections

D. Kulpa, C. Gavegnano, Colin Song, 2022, Frontiers in Immunology.

Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction

M. Lederman, R. Balderas, D. Douek, 2018, The Journal of clinical investigation.

Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART

J. Brenchley, K. Delman, R. Sékaly, 2021, PLoS pathogens.

Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption

J. Harper, Sherrie M. Jean, L. Micci, 2024, Nature immunology.